UNION operates as a privately held, clinical-stage pharmaceutical development company dedicated to the identification, development, and commercialization of treatments targeting immunological diseases. Distinguished by its small and agile structure, UNION boasts a distinctive team comprising biotech entrepreneurs and seasoned pharmaceutical executives.
Before partnering with Optio, UNION faced challenges achieving full benefits of- and scaling their incentive program. Realizing the need for a better solution, they sought a platform that not only addressed scalability but also provided support from local experts in 7P taxation law.
Another challenge faced by UNION was the lack of an easily accessible employee incentive overview. This awareness gap hindered the organization from maximizing its potential from the equity incentives.
Optio’s platform stepped in as the perfect solution to address all of UNION’s requirements. With a scalable approach, it was ready to adapt to UNION’s ever-changing needs, ensuring a seamless evolution alongside their growth. This flexibility became a key element in addressing UNION’s challenges.
To tackle the issue of employee awareness, Optio’s participant portal is a game-changer. It serves as a central hub for enhancing knowledge of the incentive program for the individual employee, which, in turn, amplifies the possible impact of the equity incentives on crucial aspects like retention, motivation, and the hiring process.
Optio’s platform also addresses cost concerns. Specializing in reducing external costs tied to auditors and valuations, Optio provides UNION with a cost-efficient solution.
Choosing Optio’s platform was the beginning of a committed partnership. Optio’s comprehensive approach, extending beyond functionality, was tailored to specifically address UNION’s unique challenges. Together, UNION and Optio collaborate through optimizing operations, enhancing efficiency, and ensuring sustained success in the dynamic business landscape.